Avocado Might Offer Route to Better Leukemia Treatment: Study
Acute myeloid leukemia (AML), also known as acute myelogenous leukemia or acute nonlymphocytic leukemia (ANLL), consists of a proliferation of the myeloid line of blood cells in the bone marrow. In a recent study, researchers have discovered a novel metabolic pathway for this devastating disease. They noted that the compound that targets the enzyme, which is critical to cancer cell growth, is found only in avocados. The research has been published in the journal Blood on March 15, 2021.
Acute myeloid leukemia (AML) cells have an atypical metabolic phenotype characterized by increased mitochondrial mass as well as a greater reliance on oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO) for survival. To exploit this altered metabolism, Dr Matthew Tcheng and his team assessed publicly available databases to identify FAO enzyme overexpression. Upon analysis, they found that VLCAD (ACADVL) was found to be overexpressed and critical to leukemia cell mitochondrial metabolism.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.